Skip to main content

Table 1 Schedule of visits and assessments

From: Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study

Assessments V0 V1 V2 V3 V4 V5 V6 V7 V8 V9 V10 V11
Scr WK1 WK3 WK4 WK5 WK6 WK7 WK8 WK9 WK10 WK11 WK12
Informed consent X            
Med history & physical exam X            
CAPS-5 X            X
PCL-5 X X X X X X X X X X X X
PSQI X X X X X X X X X X X X
PHQ-9 X X X X X X X X X X X X
QOLS X            X
WHODAS 2.0 X            X
PTGI X            X
Medication diary X X X X X X X X X X X X
Medication dosing   X X X X X X X X X X X
Medication adjustment   X X   X     X    X
Adverse effects    X X X X X X X X X X
Psychotherapy    S1 S2 S3 S4 S5 S6 S7 S8 S9 S10
Self-report of engagement    X X X X X X X X X X
Vital signs X X X X X X X X X X X X
Labs X            X
ECG X            X
  1. Shown are procedures completed at visits (V#) / weeks (WK) of study. Screening (Scr) occurs at V0 and medication reduction or initiation occurs from Weeks 1–3
  2. Abbreviations: CAPS-5 Clinician-Administered PTSD Scale for DSM-5, PCL-5 PTSD Checklist for DSM-5, PSQI Pittsburgh Sleep Quality Index, WHODAS 2.0 World Health Organization Disability Assessment Schedule 2.0, QOLS Quality of Life Scale, PHQ-9 Patient Health Questionnaire, PTGI Post Traumatic Growth Inventory, ECG 12-lead electrocardiogram